JD LYMON Group and e10 Launch eMgine HealthLogics

Share Article

New Policy Research Database Aggregates Medicaid, Medicare, State Exchange Reimbursement Rules, Rates, Coverage Policies and Information in One Platform

This valuable resource contains all the relevant information an account director needs for each state and Medicare Administrative Contractor.

JD LYMON Group and e10 announce the launch of eMgine HealthLogics, an enhanced policy research database which provides comprehensive reimbursement information from Medicaid, Medicare, and the newly formed State Exchanges in an intuitive, subscription based platform.

The reimbursement landscape for medical products has never been more complex. Medicare and Medicaid programs are constantly evolving – the rules, rates and coverage policies differ state-by-state. Key contacts and policy meetings are continuously revised. Staying current is a monumental task for any organization. eMgine HealthLogics pulls together the most critical information in a logical way to help its users understand and navigate this evolving landscape.

State by state, program by program, eMgine HealthLogics gives users an at-a-glance view of policies, pricing, eligibility, formularies, contacts… and much more. A scrollable calendar provides complete information on P&T, DUR, and key national meetings, all sortable by geography and program. eMgine HealthLogics aggregates and harmonizes program information and makes it available in an intuitive interface, accessible from any web enabled device that makes side-by-side comparisons easier and more meaningful.

“This valuable resource contains all the relevant information an account director needs for each state and Medicare Administrative Contractor," said the National Accounts Director of a U.S. Specialty Biopharmaceutical Company. "Our Patient Access and Case Managers use this convenient tool to provide patients and physicians detailed information on each state’s eligibility criteria, contacts, MCOs and their appeal process. I highly recommend the eMgine solution for any company wishing to get ahead of a competitor.”

JD LYMON and e10 were ideal collaborators. JD LYMON brings a rich expertise in reimbursement consulting to the pharmaceutical, biotechnology, and medical device industries. e10 is a marketing & design firm with strong capabilities in visual and technology design and a track record of success in the medical device sector. Both firms are proven experts who know the industry and understand how people use and consume information. The predecessor to the eMgine HealthLogics system [also jointly developed with e10] has been in use since 2008 and supported multiple new drug launches.

JD LYMON Group is a market access consulting and software solutions firm. Founded in 2007 under a different name to launch the original eMgine database, JD LYMON now provides a full range of strategic consulting services including reimbursement, health economics, evidence planning, and trial design and analysis. All JD LYMON Principals have held executive roles within other consulting organizations and have a combined 50+ years of experience in driving the commercial success of over 300 new medical products. Learn more at http://www.JDLYMON.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Chris Lyle
JD LYMON Group
(952) 891-1218
Email >
Visit website